Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
Clinical trial NCT00503841 · TERMINATED
Trial details
- NCT number
- NCT00503841
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-02-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.